today is world asthma day

THEME 2011: YOU CAN CONTROL UR ASTHMA

300 million people worldwide suffer from asthma and an estimated additional 100 million persons may be expected to develop the disease by 2025

Asthma Treatment and Control

Asthma is a long-term disease that usually not cured but controlled like diabetes, hypertension. The goal of asthma treatment is to control the disease. Good asthma control will:

• Prevent chronic and troublesome symptoms such as coughing and shortness of breath
• Reduce need of quick-relief medicines  
• Maintain good lung function
• Maintain normal activity levels and sleep through the night
• Prevent asthma attacks that could result in emergency room visit or being admitted to the hospital for treatment

The steps in asthma management includes

·        Development of Patient/Doctor Partnership

·        Identify and reduce exposure to risk factors

·        Assess, Treat and Monitor Asthma

·        Manage asthma exacerbations

·        Special considerations

WORLD ASTHMA DAY 3RD MAY 2011

WORLD ASTHMA DAY IS CELEBRATE TO INCREASE AWARENESS ABOUT ASTHMA AND IMPROVED ASTHMA CARE. THIS YEAR WORLD ASTHMA DAY THEM IS 'YOU CAN CONTROL UR ASTHMA'

broncial thermoplasty

• Bronchial thermoloasty has emerged as a newer modality of treatment for asthma. 
• During the procedure radiofrequency-generated heat delivered to the airways via a catheter inserted in the bronchial tree through a flexible bronchoscope to reduce smooth muscle quantity and contractility
• It is a three stage procedure, where lower and upper lobe bronchi are treated
• Preliminary investigation in animals and human has shown promising results

A day with Prof Ashok Shah, V P C I Delhi

Indeed it was a grate day for me and doctors from Guwahati. On 13th of March 2011 Prof Ashok Shah came to deliver his excellent talk on Sarcoidosis in India and ABPA. Prof Shah is eminent speaker and teacher, had many international and national publications. We have learn a lot form him. Recent information has been updated.......... 

PREVENTION OF VAP >>>> UPCOMING DEVICES

Over recent time some devices has been found to reduce Ventilator Associated Pneumonia. Studies have shown significant reduction in incidence of VAP and has been recommended in recent guidelines. These devices are-

1. Endrothracheal tube with subglottic secretion drainage (SSD)

2. ET tube with ultrathin cuff membrane

3. ET tube coated with anti-microbial agent

4. ET tube with SSD, LVLP cuff and constant cuff inflation pressure 

SYNDROME Z

WHAT IS SYNDROME Z??
SYNDROME Z IS A SYNDROME IN RELATION TO METABOLIC SYNDROME. OR SYNDROME X. SYNDROME X IS CHARACTERISED BY PRESENCE OF ANY OF THE 3 CRITERIA-

1. CENTRAL OBESITY , WAIST CIR >40 INCH MALE, >35 INCH FEMALE
2. FASTING INCREASE LEVEL OF TG EQUAL OR> 150 MG/DL
3.HDL CHOLESTEROL <40 MG/DL MALE, <50MG/DL FEMALE
4. BP EQUAL OR > 130/80 mmHg
5. FBS EQUAL OR > 110MG/DL

WHEN THIS METABOLIC SYNDROME CO-EXIST WITH OBSTRUCTIVE SLEEP APNEA IT IS TERMED AS SYNDROME Z

Adenosine Deaminase ( ADA) facts in tubercular pleural effusion

SOME FACT ABOUT ADA

• >ADA is an enzyme in purine salvage pathway that catalyzes the conversion of adenosine and deoxyadenosine to inosine and deoxyinosine
• >Abundant in activated T lymphocytes 
• >An ADA level >70 IU/L is highly suggestive of TB while a level < 40 IU/L virtually excludes the diagnosis of tuberculosis 
• >Meta-analysis of 40 studies from 1966 to 1999 showed the ADA sensitivity to vary between 47.1% to 100% and specificity between 0 to 100% 
• >Specificity increases when lymphocyte to neutrophil ratio in pleural fluid (>0.75) is considered in conjugation with an ADA concentration >50 IU/L 
• > In low prevalence setting (i.e. <1%) positive predictive value may be as low as 15% however negative predictive value increases 
• >In high prevalence of tuberculosis, ADA measurement is inexpensive, minimally invasive, rapid and readily accessible test that has sensitivity and specificity of 95% and 90% respectively 
• >Elevated ADA in lymphocyte rich pleural fluid has been reported in other diseases, such as rheumatoid arthritis, bronchoalveolar carcinoma, mesothelioma, mycoplasma and chlamydia pneumonia, psittacosis, paragonimiasis, infectious mononucleosis, brucellosis, mediterrianes fever, histoplasmosis, cocoidiodomycosis  and in most patient with empyema 
• >Two isoenzymes ADA1 and ADA2 
• >ADA1 is found in all cells with the highest activity observed in lymphocytes and monocytes.
• >ADA2 isoenzyme is predominantly found in monocytes/macrophages
• >ADA2 isoenzyme is primarily responsible for increase ADA activity in TB pleural effusion with a median contribution of 88% 
• >Pleural effusions with high ADA level and ADA1/total ADA ratio <0.45 makes the diagnosis of TB highly likely 
• >In immune compromised person ADA hold similar significance

RESPIRATORY UPDATE 2011 IN GUWAHATI

DEPARTMENT OF TB AND RESPIRATORY MEDICINE ALONG WITH INDIAN CHEST SOCIETY GOING TO ORGANIZE RESPIRATORY UPDATE 2011 IN GUWAHATI. ASSAM.

MOST LIKELY List of topics

1.       Evaluation and management  of pneumonia in health care setting

2.       Extra pulmonary manifestation of COPD

3.       Rational and controversies in management of obstructive airway  disease

4.       Clinical approach and treatment  of  non tubercular mycobacterium infection

5.       Diagnosis and treatment protocol for ILD

6.       Role of NIV in respiratory diseases

perfomance status of lung cancer

for more detail log on to WHO or ECOG web site

CONFERENCE ON INTERVENTIONAL PULMONOLOGY

4TH ASIA-PACIFIC CONGRESS ON BRONCHOLOGY AND INTERVENTIONAL PULMONOLOGY
JAIPUR 2012


FOR DETAIL LOG ON TO
http://www.apcb2012.com